Douglas B. Farquhar

Douglas B. Farquhar has more than 40 years of experience as a prosecutor and defense and regulatory attorney. Since joining the firm in 1997, he has advised pharmaceutical and medical device manufacturers and wholesalers, compounding pharmacies, physicians involved in clinical trials, and other individuals on a wide range of enforcement activities, including consent decrees, criminal investigations, debarment issues, arbitration proceedings, civil seizures, FDA inspection issues, and injunctions. Mr. Farquhar has a broad-based understanding of the investigatory process, having negotiated settlements and resolutions for both industry and government.

Mr. Farquhar also advises companies and individuals on adverse findings after FDA inspections. He has been active in defending companies during government investigations into drug pricing and drug and medical device fraud and abuse claims. In addition, Mr. Farquhar has represented employees and companies in investigations relating to anti-kickback laws. He has argued cases and defended companies and individuals in federal court against both civil and criminal FDA enforcement efforts, and has sued FDA in cases related to generic drug approvals and adverse FDA publicity about his clients.  He has represented individuals in FDA debarment proceedings.

Mr. Farquhar’s legal career includes seven years of service as a federal prosecutor. He was an assistant U.S. Attorney in the District of Maryland from 1990 to 1997, and clerked for the Honorable Judge Joseph H. Young, U.S. District Court in Baltimore, Maryland. Mr. Farquhar also reported for local newspapers before enrolling in law school.

Mr. Farquhar has shared his perspective on enforcement and litigation issues through frequent speaking engagements and publications.  He contributes to the firm’s FDA Law Blog, and was one of the first Chairs of the annual Enforcement Conference for the Food and Drug Law Institute.  In addition, he wrote two chapters for the FDLI publication, How to Work with FDA, focusing on seizures, injunctions, consent decrees, and stolen drug samples.  Mr. Farquhar has served on the Planning Committee and spoken regularly at the “GMP by the Sea” conference sponsored by PharmaConference.